International Journal of Tryptophan Research · 2019 · 49 citations · 118 references
Life SciencesBiochemistryNutritional SciencesMetabolismMicrobial MetabolismNeurodegenerationAlzheimer DiseaseAmino Acid MetabolismGut MicrobiotaNeurodegenerative DiseasesNeurodegenerative DisordersShikimate PathwayBacterial Shikimate PathwayGut Microbiome AlterationsGut Microbiota DysbiosisGut Microbiota EffectsMicrobial Shikimate PathwayNeurodegeneration PathogenesisTryptophan BiosynthesisTryptophan Metabolism
. Tryptophan and NQR substrate ubiquinone have common precursor chorismate in microbial shikimate pathway. Tryptophan-derived tryptamine presents in human diet and gut microbiome. Tryptamine inhibits tryptophanyl-tRNA synthetase (TrpRS) with consequent neurodegeneration in cell and animal models. Tryptophanyl-tRNA synthetase inhibition causes protein biosynthesis impairment similar to that revealed in AD. Tryptamine-induced TrpRS gene-dose reduction is associated with TrpRS protein deficiency and cell death. In animals, tryptamine treatment results in toxicity, weight gain, and prediabetes-related hypoglycemia. Sequence analysis of gut microbiome database reveals 89% to 100% ADAS nucleotide identity in American Indian (Cheyenne and Arapaho [C&A]) Oklahomans, of which ~93% being overweight or obese and 50% self-reporting type 2 diabetes (T2D). Alzheimer disease-associated sequence occurs in 10.8% of C&A vs 1.3% of healthy American population. This observation is of considerable interest because T2D links to AD and obesity. Alzheimer disease-associated sequence prevails in gut microbiome of colorectal cancer, which linked to AD. Metabolomics revealed that tryptamine, chorismate precursor quinate, and chorismate product 4-hydroxybenzoate (ubiquinone precursor) are significantly higher, while tryptophan-containing dipeptides are lower due to tRNA aminoacylation deficiency in C&A compared with non-native Oklahoman who showed no ADAS. Thus, gut microbial tryptamine overproduction correlates with ADAS occurrence. Antibiotic and diet additives induce ADAS and tryptamine. Mitogenic/cytotoxic tryptamine cause microbial and human cell death, gut dysbiosis, and consequent disruption of host-microbe homeostasis. Present analysis of 1246 participants from 17 human gut metagenomics studies revealed ADAS in cell death diseases.
118
Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life
Fredrik Bäckhed, Josefine Roswall, Yangqing Peng et al. · Cell Host & Microbe · 2015 · 3.4K citations · Full text
Life Sciences, Biology, Microbiology +14
Gut microbiome alterations in Alzheimer’s disease
N. Vogt, Robert L. Kerby, Kimberly A. Dill‐McFarland et al. · Scientific Reports · 2017 · 2.1K citations · Full text
Symptomatic atherosclerosis is associated with an altered gut metagenome
Fredrik Karlsson, Frida Fåk, Intawat Nookaew et al. · Nature Communications · 2012 · 1.4K citations · Full text
Jun Yu, Qiang Feng, Sunny H. Wong et al. · Gut · 2015 · 1.3K citations · Full text